Virtus ETF Advisers LLC - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 121 filers reported holding CARIBOU BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$102,091
+2.3%
21,358
-9.1%
0.06%
+5.1%
Q2 2023$99,816
+51.6%
23,486
+89.4%
0.06%
+63.9%
Q1 2023$65,839
-38.9%
12,399
-27.8%
0.04%
-35.7%
Q4 2022$107,796
-49.9%
17,165
-15.7%
0.06%
-34.9%
Q3 2022$215,000
+95.5%
20,369
+0.8%
0.09%
+109.8%
Q2 2022$110,000
+27.9%
20,215
+115.2%
0.04%
+7.9%
Q1 2022$86,000
-42.7%
9,392
-5.6%
0.04%
-33.3%
Q4 2021$150,0009,9490.06%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 674,196$10,174,0006.39%
72 Investment Holdings, LLC 474,067$7,154,0006.35%
Velan Capital Investment Management LP 210,695$3,179,0002.47%
PFM Health Sciences, LP 4,092,309$59,418,0002.02%
Monashee Investment Management LLC 504,377$7,611,0001.88%
CloudAlpha Capital Management Limited/Hong Kong 415,000$6,262,0001.49%
Avidity Partners Management LP 2,674,067$40,352,0000.86%
Rokos Capital Management LLP 570,359$8,604,0000.52%
Green Alpha Advisors, LLC 35,592$537,0000.36%
Tekla Capital Management LLC 699,377$9,875,0000.32%
View complete list of CARIBOU BIOSCIENCES INC shareholders